Smuggling:
illegal inflow of medicinal products in Switzerland

In 2019 the distributing channels of counterfeit and substandard medicines changed. Indian-made products often shipped through hubs in Poland, Singapore, and the UK. Unsuitable transit routes affect the stability and effectiveness of medications. High humidity and ambient temperature during transportation and storage of medicines pose an additional danger to human health.

The introduction of a simplified procedure has led to a sharp increase in the number of seized consignments.

India - 42.9%;

Eastern Europe (primarily Poland) - 26.8%;

Asia (except India, primarily Singapore) - 17.8%;

Western Europe (mainly Great Britain and Germany) - 11.7%

Other countries - 0.8%.

Erection stimulants - 91.3%;

Other prescription drugs - 3.8%;

Hypnotics and tranquilizers - 2.7%;

Drugs for weight loss - 0.2%;

Other - 2.0%.

Acquisition of drugs through uncontrolled channels poses a serious health risk. Deliveries often go without packaging, product information (dosage, restrictions on use, or possible side effects). Only doctors or pharmacists can decide whether to use a prescription drug.

Starting January 1, 2019, Swissmedic prosecutes drug offenders (in the event of a violation of the Law on Therapeutic Products) and the Federal Customs Administration (regarding violation of VAT and customs regulations).